2003
Off-Pump System Enhances Access and Visibility at Bypass Graft Connection Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Next-Generation Drug Eluting Stent Utilizes Guidant''s VISION Cobalt Chromium Stent Technology Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Next Generation Device Designed to Address Common Co-morbidity for Heart Failure Patients Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
Legislation Benefits Patients, Physicians and Medical Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Company Reiterates 2005 Introduction of First Drug Eluting Stent New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today is providing a...
Company Reiterates Guidance for 2003; Previews 2004 Full-Year Revenue and Earnings New York - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will...
New Investments and Sponsorships Bolster Guidant''s Commitment to Advanced Patient Management Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Strategic alliance allows for sharing of data and systems Milwaukee, Wis. and St. Paul, Minn. - GE Medical Systems, a division of the General Electric Company (NYSE: GE) and Guidant Corporation...
RELIANCE G Leads are First to Feature Covering to Prevent Tissue Ingrowth Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
NSIGNIA Ultra''s Unique Technology Enables Tailored Therapy Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
MADIT II patients with heart failure now eligible for Cardiac Resynchronization Therapy Defibrillator Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the...
Guidant''s Leadership in Heart Failure Therapy Continues with Landmark Study Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will conduct a live webcast of its annual...
Latest Defibrillator Expands Successful Product Portfolio Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a fourth...
Agreement Reinforces Guidant''s Leadership in Endoscopic Cardiovascular Technologies Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
* Worldwide implantable defibrillator revenue of $385 million, up 48 percent * Worldwide stent revenue of $200 million, down 14 percent * Gross margin increases to 76.1 percent * Drug eluting...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its third quarter 2003 earnings conference...
Company Resumes Product Shipment with Food and Drug Administration Approval Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Cardiac Resynchronization Therapy Defibrillator Represents the World''s Thinnest, Most Advanced System Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in...
New Position Will Lead Technology Development Strategy INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Beverly...
Updated Landmark Heart Failure Trial Data Submitted to Peer-Reviewed Journal LAS VEGAS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world...
Institute Demonstrates Guidant''s Leadership in Medical Education Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Guidant-Supported Grant Honors Late Chief Medical Officer Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...
Vulnerable Plaque Study Shows Correlation Between Lipid-Rich Plaques and Heart Attacks in Cath Lab Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
FUTURE I and II Trials Utilize Everolimus with Bioabsorbable Polymer; Results Presented Today Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
"Programmable" Polymer Capabilities Strengthen Guidant''s Development of Future Therapies for Coronary Artery Disease Indianapolis and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a...
Company Outlines Progress Toward Drug Eluting Stent Milestones; Third Quarter and Full-Year 2003 Financial Guidance Affirmed Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...
Additional Equity Investment Strengthens Guidant''s Commitment to the Development of Future Technologies for Heart Surgery Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an update on the...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that the company''s board of directors declared a third...
Latest Addition to Pacemaker Portfolio Offers Improved Therapy Options While Maintaining Size and Longevity Brussels, Belgium and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...
Calls on Conference to Seize Historic Opportunity to Improve Quality and Expand Access Through Greater Choice, Competition and Innovation Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a...
World''s Smallest Dual Chamber System Offers Enhanced Therapies to Patients at Risk of Sudden Cardiac Death Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader...
Worldwide implantable cardioverter defibrillator revenues of $377 million, up 50 percent; Worldwide stent revenue of $224 million, down 2 percent; Favorable product mix generates 75.4 percent...
Next-Generation Stent Design and Excellent Clinical Results Offer Expanded Treatment Options for Patients Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
European Trial Demonstrates Low Restenosis Rate in Stenting of Small Vessels Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Cardiac Resynchronization Therapy-Defibrillator Represents the World''s Most Advanced System Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Corporate Integrity Agreement Strengthens Guidant''s Commitment to Compliance Indianapolis, Ind. - Guidant Corporation (NYSE: GDT) today announced that it has entered into a corporate integrity...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its second quarter 2003 earnings conference...
European Approval Received; New Technology''s Clinical Trial Demonstrated Excellent Results Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Financial Guidance Updated Based on Strong Sales Companywide; Quarterly Dividend to be Paid June 30 INDIANAPOLIS - Guidant Corporation (NYSE: GDT) today announced that the company has made a $10...
No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced plans to...
X Technologies Receives FX miniRAIL U.S. Food and Drug Administration Approval; Conditions of X Technologies Acquisition Fulfilled; Agreement Expected to Close This Quarter Indianapolis, Ind. -...
Company''s Management to Provide Update on Recent Developments Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
No Risk to Patients Implanted with ANCURE ENDOGRAFT System INDIANAPOLIS - EndoVascular Technologies, Inc. (EVT), a subsidiary of Guidant Corporation, today announced that it has entered into a...
Second Clinical Trial Advances Efforts to Develop Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world...
CMS Decision Leaves Some Seniors Without Coverage for Now Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease,...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that an arbitration panel entered a preliminary finding that...
International Symposium Offers Unique Opportunity for Experts in Device and Drug Therapies to Share Knowledge Indianapolis, IN - A major international heart failure symposium co-sponsored by...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
New Trial Signifies Continued Leadership in Heart Failure Clinical Science Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Guidant's Institute for Therapy Advancement - Japan Continues Leadership in Medical Education Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
State-of-the-Art Simulation Programs Expand Guidant''s Medical Education Offerings to Physicians Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE: GDT), a world leader in the...
Meeting to be held in Indianapolis on May 19 Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
New Indication Allows Physicians to Harvest Artery in Arm For Coronary Bypass Graft Surgery Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the...
Landmark Trials Featured Indianapolis, Ind. and St. Paul, Minn. - Two Guidant Corporation (NYSE: GDT) sponsored clinical trials will be prominently featured during the 24th annual meeting of the...
Establishment of New DRG 535 is Milestone in Advancement of Heart Failure Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will host a mid-quarter conference call to provide an...
Guidant Announces CE Mark and First Implant of Newest Cardiac Resynchronization Pacemaker
The CONTAK RENEWAL TR 2 Implantable Cardiac Resynchronization Therapy Pacemaker Offers Market-leading Diagnostics and Therapy Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE:...
New Device Captures Emboli Released During Carotid Stenting Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
Results Presented at American Association of Thoracic Surgeon''s 83rd Annual Meeting Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Strategic Alliance Aimed at Expanding Options for the Treatment of Sleep-Disordered Breathing Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will participate...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ginger L. Graham, Advisor to the President, has elected...
Worldwide Implantable Defibrillator Revenue Growth of 72 Percent Changes Product Mix Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE:...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its first quarter 2003 earnings conference...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Guidant will acquire an early-stage company founded by...
VITALITY AVT Implantable Defibrillator Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE: GDT), a world leader in the...
Preliminary Data Demonstrate Mortality Benefit and Reduced Hospitalization for Heart Failure Patients CHICAGO - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and...
Limited European and Australian Accounts Affected Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it has...
Guidant Reports Positive Six-Month Clinical Results of Everolimus Eluting Coronary Stent
Data Supports Use of Everolimus for Drug Eluting Stents Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...
Study Evaluates Potential New Minimally Invasive Treatment for Carotid Artery Disease Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE: GDT), a world leader in the treatment...
Study Evaluates Therapeutic Options for Preventing Heart Attacks Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today...
Company Updates Status of Drug Eluting Stent Program Webcast/Conference Call Scheduled for Thursday, March 20, at 11:00 AM ET Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, announced today that it will host an investor briefing...
U.S. Study Continues Guidant''s Leadership in Clinical Science St. Paul, Minn. and Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular...
MULTI-LINK PENTA Stent System Brings Guidant''s Outstanding Stent Design Technology to Japanese Physicians and Patients Indianapolis, Ind. and Tokyo - Guidant Corporation (NYSE: GDT), a world...
FX miniRAIL Coronary Device Aims to Expand Physicians'' Options In the Treatment of De Novo Lesions and In-Stent Restenosis Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in...
Indianapolis, Ind. - Guidant Corporation (NYSE: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Dana G. Mead, Jr., currently vice president, Corporate...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
Company Sets Date for Annual Meeting of Shareholders Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced...
INSIGNIA Entra is Small, Smart and Long-Lasting Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease,...
Live Webcast Available Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will host a conference call to provide an...
Medicare Coverage Advisory Committee Recommends Expanding Coverage to Include MADIT II Patients Indianapolis, Ind. and St. Paul, Minn. - Guidant Corporation (NYSE and PCX: GDT), a world leader in...
Background Materials Available for Review Online Indianapolis, Ind. - Guidant today announced that background materials from Guidant have been provided to the Centers for Medicare and Medicaid...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that Ron Lattanze, president, Guidant Japan, has been...
Degois-Sainz Joins Guidant Management Committee Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced today that Nicky Spaulding currently president, Cardiac Surgery, Guidant, has been named president, Guidant Europe, Middle...
Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, today announced that it will...
Enhanced Guideline Reflects Results of MADIT II Trial Indianapolis, Ind. and Brussels, Belgium - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular...
More Than 97 Percent of Patients Studied Experienced Stable or Shrinking Aneurysm Size Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...
Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in the treatment of cardiac and vascular disease, today announced that it...
Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and vascular disease, will conduct a live webcast of its fourth quarter 2002 earnings...
VITALITY AVT Offers Complete Ventricular and Atrial Therapy Options Indianapolis, Ind. and Brussels - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiac and...